Nusano is featured in the 2024 edition of Biosphere magazine entitled “Profiles in Innovation.” Published by BioUtah, the publication highlights advancements occurring throughout Utah’s life sciences industry. In the article, Nusano’s CEO Chris...
Proprietary ion source and beam technology capable of producing approximately 10 times the current global supply of Astatine-211 Updated May 4, 2023 to add presentation materials Download PDF PRESENTATION The Nusano Medical Radioisotope Production Platform: Supplying...
NEW YORK – April 20, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced its co-founder and Chief Operating Officer (COO), Dr. Howard Lewin, will take part in a virtual event hosted by Truist Securities on Friday,...
New domestic supply source to help address critical shortage of medical radioisotopes Proprietary platform will be capable of generating up to 12 different rare isotopes simultaneously WEST VALLEY CITY, Utah – April 17, 2023 – Nusano, Inc., a company reshaping...
Jan. 11, 2023 – Citing aging infrastructure and anticipated future demand, the Welsh government is taking action to establish a stable supply of medical radioisotpes for citizens of the United Kingdom. World Nuclear News reports: The Welsh government says that, as...
